|
Biotech, Food, and Drug Legal News
Hourly and around the clock, the National Law Review's editors screen and classify breaking environmental law news and analysis authored by recognized legal professionals and our own journalists.
In-house attorneys looking for a better way to organize, vet, and easily retrieve legal news created the National Law Review online edition.
There is no log-in to access the database and new articles are added hourly.
|
FDA Chief Says CBD Is Not NBD, Urges Congressional Action
Supporters of hemp-derived cannabidiol (CBD) who hoped the Food and Drug Administration would adopt a more progressive view of CBD were disappointed when FDA Chief Robert Califf recently testified that FDA does not consider hemp-derived CBD safe enough to be sold lawfully as a dietary supplement, and urged Congress to create a new pathway to regulate CBD. Specifically, Califf stated that “CBD doesn’t fall under any particular regulatory scheme that we have” and that “[FDA] very much would like Congress to establish a regulatory pathway for CBD.”
More on CBD Regulation Here >
|
|
|
The National Law Review 708-357-3317 | info@natlawreview.com | www.natlawreview.com 3 Grant Square, #141
Hinsdale, IL 60521
|
|
|
|